These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26174109)

  • 1. Relationship Between Metabolic Syndrome and Clinical Features, and Its Personal-Social Performance in Patients with Schizophrenia.
    Saatcioglu O; Kalkan M; Fistikci N; Erek S; Kilic KC
    Psychiatr Q; 2016 Jun; 87(2):265-80. PubMed ID: 26174109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome with different antipsychotics: a multicentre cross-sectional study.
    Cerit C; Vural M; Bos Gelmez SÜ; Ozten E; Aker AT; Yıldız M
    Psychopharmacol Bull; 2010; 43(4):22-36. PubMed ID: 21240150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
    Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
    Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical correlates of social anxiety disorder comorbidity in schizophrenia].
    Güçlü O; Erkıran M; Aksu EE; Aksu H
    Turk Psikiyatri Derg; 2012; 23(1):1-8. PubMed ID: 22374625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
    Simpson GM; Glick ID; Weiden PJ; Romano SJ; Siu CO
    Am J Psychiatry; 2004 Oct; 161(10):1837-47. PubMed ID: 15465981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients.
    Lee HY; Kim DJ; Lee HJ; Choi JE; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):276-80. PubMed ID: 19059448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation between metabolic syndrome and neurocognitive and social cognitive performance of patients with schizophrenia.
    Chen S; Xia X; Deng C; Wu X; Han Z; Tao J; Wu X
    Psychiatry Res; 2020 Jun; 288():112941. PubMed ID: 32334274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression in schizophrenia: comparison of first- and second-generation antipsychotic drugs.
    Mauri MC; Moliterno D; Rossattini M; Colasanti A
    Schizophr Res; 2008 Feb; 99(1-3):7-12. PubMed ID: 18055177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
    Chakos M; Lieberman J; Hoffman E; Bradford D; Sheitman B
    Am J Psychiatry; 2001 Apr; 158(4):518-26. PubMed ID: 11282684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: findings from the CLAMORS study.
    Arango C; Bobes J; Kirkpatrick B; Garcia-Garcia M; Rejas J
    Eur Neuropsychopharmacol; 2011 Dec; 21(12):867-75. PubMed ID: 21477998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia.
    Rocca P; Montemagni C; Castagna F; Giugiario M; Scalese M; Bogetto F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):373-9. PubMed ID: 19211031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Add-on of aripiprazole improves outcome in clozapine-resistant schizophrenia.
    De Risio A; Pancheri A; Simonetti G; Giannarelli D; Stefanutto L; Gentile B
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1112-6. PubMed ID: 21447367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control study.
    Barrio P; Batalla A; Castellví P; Hidalgo D; García M; Ortiz A; Grande I; Pons A; Parellada E
    Int Clin Psychopharmacol; 2013 Jul; 28(4):164-70. PubMed ID: 23587986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and its factors affect cognitive function in chronic schizophrenia complicated by metabolic syndrome.
    Li C; Zhan G; Rao S; Zhang H
    J Nerv Ment Dis; 2014 Apr; 202(4):313-8. PubMed ID: 24647221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A twenty-four-week, open-label study on ziprasidone's efficacy and influence on glucolipid metabolism in patients with schizophrenia and metabolic disorder.
    Li CH; Shi L; Zhan GL; Rao SZ; Zhang H
    Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2136-40. PubMed ID: 23893178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of the Spanish version of the Personal and Social Performance scale in schizophrenia.
    Apiquian R; Elena Ulloa R; Herrera-Estrella M; Moreno-Gómez A; Erosa S; Contreras V; Nicolini H
    Schizophr Res; 2009 Jul; 112(1-3):181-6. PubMed ID: 19398302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of switching to aripiprazole from atypical antipsychotics in patients with schizophrenia.
    Kim SW; Shin IS; Kim JM; Lee JH; Lee YH; Yang SJ; Yoon JS
    Clin Neuropharmacol; 2009; 32(5):243-9. PubMed ID: 19620849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.
    Azorin JM; Spiegel R; Remington G; Vanelle JM; Péré JJ; Giguere M; Bourdeix I
    Am J Psychiatry; 2001 Aug; 158(8):1305-13. PubMed ID: 11481167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.